(April 15, 2024, 1:59 PM EDT) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) agreed to transfer cases involving “Maximum Strength” labeling on over-the-counter cough and cold medications containing the active ingredient phenylephrine (PE) to the multidistrict litigation for cases alleging that the medications are ineffective at relieving nasal congestion....